Symbol="RXDX"
AssetType="Common Stock"
Name="Prometheus Biosciences Inc"
Description="Prometheus Biosciences, Inc., a biopharmaceutical company, is dedicated to the discovery, development, and commercialization of complementary diagnostic and precision therapeutics for the treatment and diagnosis of inflammatory bowel diseases (IBD). The company is headquartered in San Diego, California."
CIK="1718852"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3050 SCIENCE PARK ROAD, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="9558515000"
EBITDA="-161611008"
PERatio="None"
PEGRatio="None"
BookValue="14.62"
DividendPerShare="0"
DividendYield="0"
EPS="-3.54"
RevenuePerShareTTM="0.093"
ProfitMargin="0"
OperatingMarginTTM="-40.65"
ReturnOnAssetsTTM="-0.201"
ReturnOnEquityTTM="-0.333"
RevenueTTM="3995000"
GrossProfitTTM="-106039000"
DilutedEPSTTM="-3.54"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.718"
AnalystTargetPrice="190"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="627.82"
PriceToBookRatio="19.88"
EVToRevenue="610.46"
EVToEBITDA="-33.16"
Beta="-0.486"
num_52WeekHigh="199.98"
num_52WeekLow="27.3"
num_50DayMovingAverage="189.46"
num_200DayMovingAverage="112.93"
SharesOutstanding="47811700"
DividendDate="None"
ExDividendDate="None"
symbol="RXDX"
open="199.92"
high="199.92"
low="199.92"
price="199.92"
volume="0.00"
latest_trading_day="2023-06-16"
previous_close="199.92"
change="0.00"
change_percent="0.0000%"
aroon_positive_momentum_days="94"
aroon_negative_momentum_days="0"
trend_strength="Strong Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Overbought"
value_analysis="Overvalued"
Aroon_change="FALSE"
Aroon_momentum="94"
Volume_recent_avg="947558"
Change_recent_avg="-0.02"
Delta_recent_avg="3.18"
Variance_recent_avg="1.59"
Change_ratio_recent_avg="-0.04"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="94"
Aroon_momentum_negative="6"
image_negative_thumbnail_id_1="493"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0112.jpeg"
image_negative_thumbnail_id_2="1159"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0193.jpeg"
image_neutral_thumbnail_id_1="541"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0058.jpeg"
image_neutral_thumbnail_id_2="564"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_positive_thumbnail_id_1="957"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0119.jpeg"
image_positive_thumbnail_id_2="663"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0045.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1187"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
